Report Code : CVMI29123751 | Published Date : March 26, 2025
nan
Reasons To Buy
nan
Scope
nan
Key Players
- Allergy Immunotherapy Market – Stallergenes Greer
- ALK-Abelló A/S
- Merck KGaA
- Allergy Therapeutics
- HAL Allergy Group
- DBV Technologies
- Jubilant HollisterStier
- Anergis SA
- Biomay AG
- Circassia Pharmaceuticals.
Europe Allergy Immunotherapy Market Report
-
1. Europe Allergy Immunotherapy Market Research Report
- 1.1 Study Objectives
- 1.2 Europe Allergy Immunotherapy Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Europe Allergy Immunotherapy Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Type
- 2.1.2 By Allergy Type
- 2.1.3 By End-user
- 2.1.4 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Type, By Allergy Type, By End-user, By Country
- 3.3. Opportunities – By Type, By Allergy Type, By End-user, By Country
- 3.4. Trends – By Type, By Allergy Type, By End-user, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Europe Allergy Immunotherapy Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Subcutaneous Immunotherapy (SCIT)
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Sublingual Immunotherapy (SLIT)
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Seasonal Allergies
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Perennial Allergies
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Food Allergies
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.4 Others
- 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Hospitals
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Clinics
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Homecare
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 Europe
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8.2 Europe Allergy Immunotherapy Market - Opportunity Analysis Index,
By Type,
By Allergy Type,
By End-user,
and Region, 2024 - 2031
- 9.1.1 Subcutaneous Immunotherapy (SCIT)
- 9.1.2 Sublingual Immunotherapy (SLIT)
- 9.2.1 Seasonal Allergies
- 9.2.2 Perennial Allergies
- 9.2.3 Food Allergies
- 9.2.4 Others
- 9.3.1 Hospitals
- 9.3.2 Clinics
- 9.3.3 Homecare
- 9.4.1 Germany
- 9.4.2 United Kingdom
- 9.4.3 France
- 9.4.4 Spain
- 9.4.5 Italy
- 9.4.6 Russia
- 9.4.7 Netherlands
- 9.4.8 Poland
- 9.4.9 Rest of Europe
- 9.7.1 Company 1 (Germany)
- 9.7.2 Company 2 (United Kingdom)
- 9.7.3 Company 3 (United Kingdom)
- 10.2.1 Allergy Immunotherapy Market – Stallergenes Greer
- 10.2.2 ALK-Abelló A/S
- 10.2.3 Merck KGaA
- 10.2.4 Allergy Therapeutics
- 10.2.5 HAL Allergy Group
- 10.2.6 DBV Technologies
- 10.2.7 Jubilant HollisterStier
- 10.2.8 Anergis SA
- 10.2.9 Biomay AG
- 10.2.10 Circassia Pharmaceuticals.
-
9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.6 Regional Trends Analysis
9.7 Europe Europe Allergy Immunotherapy Market Research Report - Company Profiles
-
10.1 Strategic Dashboard of Top Market Players
10.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
12. Principal Presumptions and Acronyms